-
Loading metrics
Open Access
Peer-reviewed
Research Article
Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials
-
Christine M. Lovly ,
Contributed equally to this work with: Christine M. Lovly, Kimberly Brown Dahlman, Laurel E. Fohn, Zengliu Su
Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Kimberly Brown Dahlman ,
Contributed equally to this work with: Christine M. Lovly, Kimberly Brown Dahlman, Laurel E. Fohn, Zengliu Su
Affiliation Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Laurel E. Fohn ,
Contributed equally to this work with: Christine M. Lovly, Kimberly Brown Dahlman, Laurel E. Fohn, Zengliu Su
Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Zengliu Su ,
Contributed equally to this work with: Christine M. Lovly, Kimberly Brown Dahlman, Laurel E. Fohn, Zengliu Su
Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Dora Dias-Santagata,
Affiliation Translational Research Laboratory, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Donna J. Hicks,
Affiliation Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
⨯ -
Donald Hucks,
Affiliation Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
⨯ -
Elizabeth Berry,
Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Charles Terry,
Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
MarKeesa Duke,
Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Yingjun Su,
Affiliation Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Tammy Sobolik-Delmaire,
Affiliation Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Ann Richmond,
Affiliation Department of Cancer Biology, Department of Veterans Affairs, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Mark C. Kelley,
Affiliation Division of Surgical Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ -
Cindy L. Vnencak-Jones,
Affiliation Departments of Pathology, Microbiology, Immunology and Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
⨯ -
A. John Iafrate,
Affiliation Translational Research Laboratory, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Jeffrey Sosman ,
¶These senior authors also contributed equally to this work.
Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ - [ ... ],
-
William Pao
* E-mail: william.pao@vanderbilt.edu
Affiliation Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯ - [ view all ]
- [ view less ]
Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials
- Christine M. Lovly,
- Kimberly Brown Dahlman,
- Laurel E. Fohn,
- Zengliu Su,
- Dora Dias-Santagata,
- Donna J. Hicks,
- Donald Hucks,
- Elizabeth Berry,
- Charles Terry,
- MarKeesa Duke
- Published: April 20, 2012
- https://doi.org/10.1371/journal.pone.0035309